Arushi Gulati

University of California, San Francisco

Papers

2

Total Citations

28

H-Index

2

About

Arushi Gulati is a leading researcher in head and neck surgical oncology, with a focused expertise in human papillomavirus (HPV)-positive oropharynx squamous cell carcinoma (OPSCC). Her work bridges the critical gap between surgical outcomes and patient-centered quality of life, particularly in the context of transoral robotic surgery (TORS). Gulati’s most cited study (2021, 21 citations) provides a landmark risk stratification for pathologic extranodal extension and other adverse features after TORS, enabling more personalized patient consultations and surgical decision-making for HPV-positive OPSCC. Building on this, her prospective quality of life analysis (2023, 7 citations) is among the first to demonstrate that surgery-alone approaches can preserve functional outcomes without compromising oncologic control, challenging traditional multimodality paradigms. By quantifying both histopathologic risks and survivorship experiences, Gulati has established herself as a key voice in de-escalation strategies for HPV-driven cancers. Her work directly informs clinical guidelines and empowers patients with evidence-based expectations, making her contributions essential reading for surgeons, oncologists, and researchers committed to optimizing both cure and quality of life in head and neck cancer care.

Research Focus

Key Achievements

2
H-Index
2
Papers
28
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer
21 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: University of California, San Francisco

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago